Cargando…

Heterologous COVID-19 Vaccination and Booster with mRNA Vaccine Provide Enhanced Immune Response in Patients with Cirrhosis: A Prospective Observational Study

This study aimed to evaluate the antibody and cellular responses to different coronavirus 2019 (COVID-19) vaccination regimens in patients with cirrhosis and to assess the antibody response after a vaccine booster. We conducted a prospective observational study of 89 patients with cirrhosis and 41 h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sripongpun, Pimsiri, Pinpathomrat, Nawamin, Sophonmanee, Ratchanon, Ongarj, Jomkwan, Seepathomnarong, Purilap, Seeyankem, Bunya, Chamroonkul, Naichaya, Piratvisuth, Teerha, Kaewdech, Apichat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534824/ https://www.ncbi.nlm.nih.gov/pubmed/37766131 http://dx.doi.org/10.3390/vaccines11091455

Ejemplares similares

Heterologous SARS-CoV-2 vaccine triggers more humoral immune responses among patients with liver cirrhosis
por: Kaewdech, Apichat, et al.
Publicado: (2022)

T-Cell Responses Induced by an Intradermal BNT162b2 mRNA Vaccine Booster Following Primary Vaccination with Inactivated SARS-CoV-2 Vaccine
por: Sophonmanee, Ratchanon, et al.
Publicado: (2022)

Regulatory T Cells Decreased during Recovery from Mild COVID-19
por: Seepathomnarong, Purilap, et al.
Publicado: (2022)

Impaired neutralizing antibodies and preserved cellular immunogenicity against SARS-CoV-2 in systemic autoimmune rheumatic diseases
por: Intapiboon, Porntip, et al.
Publicado: (2022)

The efficacy of branched-chain amino acid granules to restore phagocytic activity in cirrhosis patients, a randomized controlled trial
por: Chamroonkul, Naichaya, et al.
Publicado: (2023)

Validation of the “Six-and-Twelve” Prognostic Score in Transarterial Chemoembolization–Treated Hepatocellular Carcinoma Patients
por: Kaewdech, Apichat, et al.
Publicado: (2021)

Clinical Utility of SCALE-B to Predict Hepatitis B Virus Relapse, Hepatitis B Surface Antigen Loss After Antiviral Cessation in Asian Patients After 2-Year Follow-up
por: Kaewdech, Apichat, et al.
Publicado: (2022)

ABO Blood Group Differentials on Survival in Hepatocellular Carcinoma Patients Treated with Chemoembolization
por: Bannangkoon, Kittipitch, et al.
Publicado: (2021)

Utility of handgrip strength (HGS) and bioelectrical impedance analysis (BIA) in the diagnosis of sarcopenia in cirrhotic patients
por: Luengpradidgun, Lalida, et al.
Publicado: (2022)

FAIL-T (AFP, AST, tumor sIze, ALT, and Tumor number): a model to predict intermediate-stage HCC patients who are not good candidates for TACE
por: Kaewdech, Apichat, et al.
Publicado: (2023)

Coronavirus Disease 2019 Vaccinations in Patients With Chronic Liver Disease and Liver Transplant Recipients: An Update
por: Sripongpun, Pimsiri, et al.
Publicado: (2022)

Immunogenicity and Safety of an Intradermal BNT162b2 mRNA Vaccine Booster after Two Doses of Inactivated SARS-CoV-2 Vaccine in Healthy Population
por: Intapiboon, Porntip, et al.
Publicado: (2021)

Diagnostic performance of endoscopic ultrasound-guided tissue acquisition by EUS-FNA versus EUS-FNB for solid pancreatic mass without ROSE: a retrospective study
por: Wong, Thanawin, et al.
Publicado: (2022)

HBV seroprevalence and liver fibrosis status among population born before national immunization in Southern Thailand: Findings from a health check-up program
por: Sono, Supinya, et al.
Publicado: (2022)

HBV DNA level could predict significant liver fibrosis in HBeAg negative chronic hepatitis B patients with biopsy indication
por: Praneenararat, Surat, et al.
Publicado: (2014)

Immunogenicity and safety of an intradermal ChAdOx1 nCoV-19 boost in a healthy population
por: Pinpathomrat, Nawamin, et al.
Publicado: (2022)

Author Correction: Immunogenicity and safety of an intradermal ChAdOx1 nCoV-19 boost in a healthy population
por: Pinpathomrat, Nawamin, et al.
Publicado: (2022)

The use of Andrographis paniculata and its effects on liver biochemistry of patients with gastrointestinal problems in Thailand during the COVID-19 pandemic: a cross sectional study
por: Kaewdech, Apichat, et al.
Publicado: (2022)

Humoral Immunogenicity of mRNA Booster Vaccination after Heterologous CoronaVac-ChAdOx1 nCoV-19 or Homologous ChAdOx1 nCoV-19 Vaccination in Patients with Autoimmune Rheumatic Diseases: A Preliminary Report
por: Intapiboon, Porntip, et al.
Publicado: (2023)

Hepatitis B screening rates and reactivation in solid organ malignancy patients undergoing chemotherapy in Southern Thailand
por: Laiwatthanapaisan, Ratchapong, et al.
Publicado: (2019)

Clinical Features, Endoscopic Findings, and Predictive Factors for Mortality in Tissue-Invasive Gastrointestinal Cytomegalovirus Disease between Immunocompetent and Immunocompromised Patients
por: Wetwittayakhlang, Panu, et al.
Publicado: (2021)

Phlegmonous Proctitis: A Rare Entity of the Presentation of Proctitis
por: Kaewdech, Apichat, et al.
Publicado: (2018)

Challenges in the discontinuation of chronic hepatitis B antiviral agents
por: Kaewdech, Apichat, et al.
Publicado: (2021)

Amoxycillin-Clavulanic Acid-Induced Esophageal Ulcer: An Unusual Cause
por: Kaewdech, Apichat, et al.
Publicado: (2020)

Comparison between Computer Tomography and Magnetic Resonance Imaging in the Diagnosis of Small Hepatocellular Carcinoma
por: Lertpipopmetha, Korn, et al.
Publicado: (2016)

The effect of fiber supplementation on the prevention of diarrhea in hospitalized patients receiving enteral nutrition: A meta-analysis of randomized controlled trials with the GRADE assessment
por: Kaewdech, Apichat, et al.
Publicado: (2022)

Re-bleeding and its predictors after capsule endoscopy in patients with obscure gastrointestinal bleeding in long-term follow-up
por: Wetwittayakhlang, Panu, et al.
Publicado: (2019)

Postoperative outcomes of resectable periampullary cancer accompanied by obstructive jaundice with and without preoperative endoscopic biliary drainage
por: Pattarapuntakul, Tanawat, et al.
Publicado: (2022)

Homologous and Heterologous Covid-19 Booster Vaccinations
por: Atmar, Robert L., et al.
Publicado: (2022)

Heterologous booster vaccination with CoronaVac following prime vaccination with mRNA vaccine
por: Goh, Yun Shan, et al.
Publicado: (2022)

Heterologous booster vaccination with CoronaVac following prime vaccination with mRNA vaccine
Publicado: (2023)

Value and risk of percutaneous liver biopsy in patients with cirrhosis and clinical suspicion of autoimmune hepatitis
por: Sripongpun, Pimsiri, et al.
Publicado: (2021)

Acute‐on‐chronic liver failure: Epidemiology, prognosis, and outcome of a multicenter study in Thai population
por: Chirapongsathorn, Sakkarin, et al.
Publicado: (2022)

Validation of prognostic scores predicting mortality in acute liver decompensation or acute-on-chronic liver failure: A Thailand multicenter study
por: Teerasarntipan, Tongluk, et al.
Publicado: (2022)

Using an effective TB vaccination regimen to identify immune responses associated with protection in the murine model
por: Pinpathomrat, Nawamin, et al.
Publicado: (2021)

Heterologous SARS-CoV-2 Booster Vaccinations – Preliminary Report
por: Atmar, Robert L., et al.
Publicado: (2021)

Heterologous booster COVID-19 vaccination elicited potent immune responses in HCWs
por: Saltoğlu, Neşe, et al.
Publicado: (2022)

Neutralizing antibodies induced by homologous and heterologous boosters in CoronaVac vaccines in Chile
por: Acevedo, Johanna, et al.
Publicado: (2023)

Effectiveness of Heterologous COVID-19 Vaccine Booster in Korean Elderly Population, 2022
por: Park, Seon Kyeong, et al.
Publicado: (2023)

Heterologous COVID-19 Booster Vaccination in the Chronic Disorder of Consciousness: A Pilot Study
por: Pugliese, Maria Elena, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rllhora7aifjcgcab9qdlhlelc